Commit Biologics to present data on its Bispecific Complement Engaging platform at the 16th International Conference on Complement Therapeutics

Commit Biologics United Kingdom United States of America Denmark New York Ontario California

Commit Biologics is pioneering a novel approach to activating the complement component of the immune system to treat cancer and autoimmune diseases Poster to be presented on Commit's Bispecific Complement Engaging (BiCE™) platformView original content:https://www.prnewswire.co.uk/news-releases/commit-biologics-to-present-data-on-its-bispecific-complement-engaging-bice-platform-at-the-16th-international-conference-on-complement-therapeutics-302167268.html